Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Summary: Background Androgens have striking effects on skeletal muscle, but the effects on human cardiac muscle function are not well defined, neither has the role of metabolic activation (aromatization, 5α reduction) of testosterone on cardiac muscle been directly studied. Objective To assess the effects of testosterone and nandrolone, a non‐amplifiable and non‐aromatizable pure androgen, on cardiac muscle function in healthy young men. Design Double‐blind, randomized, placebo‐controlled, three‐arm parallel group clinical trial. Setting Ambulatory care research centre. Participants Healthy young men randomized into three groups of 10 men. Intervention Weekly intramuscular injections of testosterone (200 mg mixed esters), nandrolone (200 mg nandrolone decanoate) or matching (2 ml arachis oil vehicle) placebo for 4 weeks. Main outcome measures Comprehensive measures of cardiac muscle function involving transthoracic cardiac echocardiography measuring myocardial tissue velocity, peak systolic strain and strain rates, and bioimpedance measurement of cardiac output and systematic vascular resistance. Results Left ventricular (LV) function (LV ejection fraction, LV modified TEI index), right ventricular (RV) function (ejection area, tricuspid annular systolic planar motion, RV modified TEI index) as well as cardiac afterload (mean arterial pressure, systemic vascular resistance) and overall cardiac contractility (stroke volume, cardiac output) were within age‐ and gender‐specific reference ranges and were not significantly (P < 0·05) altered by either androgen or placebo over 4 weeks of treatment. Minor changes remaining within normal range were observed solely within the testosterone group for: increased LV end‐systolic diameter (30 ± 7 vs. 33 ± 5 mm, P = 0·04) and RV end‐systolic area (12·8 ± 1·3 vs. 14·6 ± 3·3 cm 2, P = 0·04), reduced LV diastolic septal velocity (Em, 9·5 ± 2·6 vs. 8·7 ± 2·0 cm/s, P = 0·006), increased LV filling pressure (E/Em ratio, 7·1 ± 1·6 vs. 8·3 ± 1·8, P = 0·02) and shortened PR interval on the electrocardiogram (167 ± 13 vs. 154 ± 12, P = 0·03). Conclusion Four weeks of treatment with testosterone or nandrolone had no benefical or adverse effects compared with placebo on cardiac function in healthy young men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ommen, S. R., Nishimura, R. A., Appleton, C. P., Miller, F. A., Oh, J. K., Redfield, M. M., & Tajik, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1788 · Cited by 2,790
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544
Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men1
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, J., Lee, W. P., Bunnell, T. J., & Casaburi, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3733 · Cited by 522
Franke, W. W., & Berendonk, B. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1262 · Cited by 457
Malkin, C. J., Pugh, P. J., West, J. N., van Beek, E. J. R., Jones, T. H., & Channer, K. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi443 · Cited by 413
Cited by
Achar, S., Rostamian, A., & Narayan, S. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.013 · Cited by 265
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
Sartorius, G. A., Ly, L. P., & Handelsman, D. J. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12550 · Cited by 44
Self-citationSalem, J.-E., Nguyen, L. S., Hammoudi, N., Preud'homme, G., Hulot, J.-S., Leban, M., Funck-Brentano, C., Touraine, P., Isnard, R., Bachelot, A., et al. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.10.017 · Cited by 17
“[13, 17] The overall beneficial effect of testosterone in HF is currently attributed to peripheral vasodilatation, improvement in general metabolism with increase of lean body and muscle mass, increase of hemoglobin”
Background
Metadata
- Authors
- Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2007-01-08
- Volume
- 66
- Issue
- 2
- Pages
- 235-245
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2038201411
- Cited by
- 55
- References
- 13
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study. https://app.cochat.ai/papers/10.1111/j.1365-2265.2006.02715.x
- The paper
- Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J. (2007). Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02715.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.